Widely expressed CD9 and CD81 tetraspanin proteins are implicated in oocyte fertilization, somatic cell fusion, adhesion, signaling, proliferation, tumor progression, and infectious disease processes. Nonetheless, there are profound gaps in our knowledge of the basic mechanisms whereby these molecules function. Recent data indicates that CD9 and CD81 form direct, lateral associations with newly discovered IgSF proteins, EWI-2 and EWI-F, bringing them into functionally relevant complexes with a3B1 and a4B1 integrins. Our preliminary data also suggest that EWI proteins bind to counter-receptors on apposing cells, while CD9-EWI and CD81-EWI complexes interact intracellularly with cytoskeletal/cytoplasmic elements. CD9 and CD81 also interact laterally with themselves and other tetraspanins. We propose to first identify and characterize counter-receptors for EWI-2 and EWI-F. Second, we will determine functionally important residues within CD9, CD81 and EWI protein cytoplasmic tails, and then we will identify tail associated intracellular proteins. Third, direct primary associations at the core of CD9/CD81-EWI protein complexes will be disrupted. We will mutate both tetraspanin homodimerization sites, and tetraspanin-EWI protein interactions sites. Fourth, we will determine critical features of CD9 and CD81, particularly in the transmembraine regions, important for associations with a4B1 and a3B1 integrins, other tetraspanins, cholesterol, and gagliosides. Fifth, we will use our panel of tetraspanin and EWI protein mutants in functional assays, involving integrin-dependent adhesion strengthening, cell morphology, motility, fusion, and signaling. From these experiments, we sill learn key structural features of CD9 and CD81 that enable them to play a central coordinating role in multicomponent transmembrane complexes. Also, our studies will add an important new lateral dimension to the a4B1and a3B1 integrins, for which studies have historically focused mostly on ligand binding domains and cytoplasmic tails. Finally, the lessons learned here for CD9 and CD81 will be applicable to other tetraspanins, which also contribute to a wide variety of physiological activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM038903-19
Application #
6929698
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Flicker, Paula F
Project Start
1987-08-01
Project End
2008-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
19
Fiscal Year
2005
Total Cost
$307,800
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Malhotra, Deepali; Fletcher, Anne L; Astarita, Jillian et al. (2012) Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 13:499-510
Sharma, Chandan; Rabinovitz, Isaac; Hemler, Martin E (2012) Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin ?6?4. Cell Mol Life Sci 69:2233-44
Wang, Hong-Xing; Li, Qinglin; Sharma, Chandan et al. (2011) Tetraspanin protein contributions to cancer. Biochem Soc Trans 39:547-52
Wang, Hong-Xing; Kolesnikova, Tatiana V; Denison, Carilee et al. (2011) The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci 124:2702-10
Lafleur, Marc A; Xu, Daosong; Hemler, Martin E (2009) Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis. Mol Biol Cell 20:2030-40
Xu, Daosong; Sharma, Chandan; Hemler, Martin E (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 23:3674-81
Kolesnikova, Tatiana V; Kazarov, Alexander R; Lemieux, Madeleine E et al. (2009) Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo. Neoplasia 11:77-86, 4p following 86
Hemler, Martin E (2008) Targeting of tetraspanin proteins--potential benefits and strategies. Nat Rev Drug Discov 7:747-58
Fiorentino, Michelangelo; Zadra, Giorgia; Palescandolo, Emanuele et al. (2008) Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest 88:1340-8
Sharma, Chandan; Yang, Xiuwei H; Hemler, Martin E (2008) DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Mol Biol Cell 19:3415-25

Showing the most recent 10 out of 67 publications